by Carolyn Thomas ♥ @HeartSisters
It’s fashionable these days for medical conference organizers, journal editors and researchers to boast about how “patient-focused” they are whenever they seek perspectives shared by patients with lived experience. But does boasting make it so?
Some of this patient focus has seemed a bit tepid to me. It’s as if they’re saying they want the patient voice – sort of, maybe, but not really. Here’s what I mean by that:
1. Academic Publishers: At some point during the two-year adventure of writing my book, A Woman’s Guide to Living with Heart Disease, a standard author questionnaire arrived one day from my publisher, Johns Hopkins University Press. One of the first questions was:
“Is this book based on your academic thesis?”
(Thesis? What thesis?)
Then this question:
“Why this book? Why now? And why are YOU the person to write this book?”
(At this point, I had to restrain my outside voice from responding: “Ahem! YOU called ME, remember?!)
The JHUP Executive Editor had approached me about the book idea because she’d been reading my Heart Sisters blog at the same time her team had made a recent editorial decision to expand their titles to non-academic authors (i.e. people without lots of letters after their names). But somehow, that decision wasn’t shared with the JHUP staff who were still sending out the same author questionnaires they’d always sent out.
2. Medical Conferences: Lucien Engelen of Radboud University in the Netherlands coined the term and ultimate hashtag #PatientsIncluded in 2010. He defined this as a global trend in medical conferences which specifically invite patients to join doctors “in the program, on the stage, and in the audience” – truly a seismic shift at the time, as illustrated by one unnamed physician’s clear objection:
“I spend all day in my clinic listening to patients. Why should I have to listen to patients when I go to my medical conferences?”
Happily, many medical conference organizers both endorsed and applied Engelen’s innovative #PatientsIncluded concept in practice.
The best role model, in my opinion, was Stanford University’s Dr. Larry Chu. He founded the Medicine X conferences which ran for a number of years at Stanford. I was honoured to be selected as one of 30 ePatient Scholars who applied to attend the first MedX conference in 2012. Selection was based on application criteria like “a history of patient engagement, community outreach and patient advocacy.” Dr. Chu and his team also offered registration/travel/hotel bursaries to qualifying patients. We were treated like welcomed guests at every turn. And before we even arrived in Palo Alto, his MedX conference planning committee had included patients – an unheard-of concept until then.
One truly unique innovation at MedX (that I’m guessing originated from one of those patients on the planning committee) was a large room designated as the Patients’ Quiet Lounge, complete with soft lighting and rows of comfy recliners for rest breaks between speaker sessions. Every day, the Patients’ Quiet Lounge was profoundly helpful to me and other patients coping with assorted debilitating symptoms and long days (although I also encountered a number of physicians who had discovered the Patients’ Quiet Lounge, too – and were napping right alongside us patients). See also: “We Are All Patients. “No, You’re Not.”
Of course, not all #PatientsIncluded conferences could meet Dr. Chu’s stellar Medicine X standards.
One example of #PatientsIncluded “Lite” happened after I was invited to be a member of a discussion panel at a Mayo Clinic medical conference on women and heart disease, three years after Stanford’s MedX started.
I was absolutely over the moon to be invited to speak at Mayo (my first time back in seven years, since I’d first been invited to attend their annual WomenHeart Science & Leadership training for patient advocates). At least, I was over the moon right up until I opened the conference program on Day One. I saw immediately that the professionals on our panel were listed by name along with a brief bio. But I was nameless, listed on the programs merely as “Patient Representative”.
I was stunned! Like all of the other conference speakers, I’d been invited and confirmed months earlier. Organizers were certainly aware well in advance that I was indeed the person who would be showing up for our panel.
To some people, this may seem like a minor slight that barely matters – except that it does matter.
And I was soon to learn that my experience was not uncommon. When Toronto’s Kate Robson, for example, told me about being invited to speak at a maternal and child health conference, here’s how she described it:
“I was surprised to see that the only speakers who did NOT have their biographies included in the conference program were the patient and family representatives.
“The organizers did not acknowledge that we should be presented and introduced in the same way as the other invited speakers. At the end, I was given a $10 gift card for my conference contribution.”
What strikes me about Kate’s story is the potential chasm between the conference organizers’ thoughtful decision to include a patient-family perspective – and the shift in attitude and policy that such a decision actually requires in real life.
And the chasm is not unique to medical conferences.
3. Medical Journal Articles: Over the years, I’ve had four patient opinion essays published in the (truly patient-focused) British Medical Journal (BMJ*). But when their editor-in-chief decided to elevate my most recent draft manuscript to an Editorial in BMJ-Open Heart instead of an opinion piece, I was told I’d now need to open an account with Scholar One. That’s the name of the the web-based software which the BMJ uses to handle manuscript tracking for its academic authors.
But the trouble with asking a lowly thesis-free patient who’s not an academic to open an online account with Scholar One was that I was unable to get past the first required field on their account application, which asked:
“What is the name of your institution?”
(Yes, I am in fact a lowly thesis-free and institution-free patient).
Does anybody at the BMJ know that the patients they’re inviting to submit are essentially unable to access the required technology? Is anybody at that journal able to amend existing forms to make them appropriate for institution-free patient partners? Making it impossible for patients to get past a required field on a required form is essentially excluding patients entirely. Scholar One is technology that works for journal editors and the academics who submit papers to their journals. It does NOT work for regular people, and it sure doesn’t work for sick people.
I had to ask BMJ Open Heart editorial assistant Christine Janssen-Seijkens to manually stick-handle every stage of the publication process for me – all because patients don’t have institutions. (Thank you again, Christine!)
See also: Patient advocate Carly Medosch explains why she and so many others continue to advocate for patients despite their own ongoing medical issues: My Open Letter to #PatientsIncluded Conferences
4. Medical research:
The Canadian Institute of Health Research (CIHR) is a federal agency responsible for funding health and medical research in Canada. My next and final example reflects on how CIHR requests background information from the patient partners invited to participate in those research projects. This is important, by the way. Did you know that cardiac research is shown to be “more relevant, more applicable, and of higher quality if patients are involved in the research process?” (1)
- creation of new companies or organizations furthering the production or use of research
- development of tools, including software
- intellectual property, including patents
.
1. E. Vroonland et al. “Patient involvement in cardiovascular research: a qualitative impact evaluation”, Research Involvement and Engagement, October 14, 2019.
.
NOTE FROM CAROLYN: I wrote more about how engaged patient partners can impact health care in “A Woman’s Guide to Living with Heart Disease”. You can ask for it at your local library or bookshop (please support your favourite independent booksellers) or order it online (paperback, hardcover or e-book) at Amazon – or order it directly from Johns Hopkins University Press; use their code HTWN to save 30% off the list price when you order.
.
Q: Have you had a positive experience being included as a patient partner? What worked, and what could have been better?
♥
See also:
*My previous patient essays published in the BMJ (no PhD required):
♥ Why Physicians Must Stop Saying: “We Are All Patients“
♥ My Experience of Patient Peer Review
♥ Yet Another Cardiac Risk Calculator?
♥ What I Wish I’d Known Before my Hospital Discharge
♥ My Editorial published in BMJ-Open Heart: Heart Failure: it’s Finally Time to Change the F-Word
.

Carolyn, I thought of you when I read this in Heather Cox Richardson’s daily Letters from An American on March 18th.
When I read the last line, I couldn’t stop laughing – even though it’s not at all funny. You can’t make this shit up!
Also today, President Joe Biden issued an executive order to advance women’s health research to integrate women’s health into federal research initiatives, strengthening data collection and making funding available for research in a comprehensive effort to equalize attention to men’s and women’s health across their lifespans. The federal government did not require women’s health to be included in federally funded medical research until 1993. In a speech today, First Lady Jill Biden recalled that in the early 1970s, researchers studying estrogen’s effect in preventing heart attacks selected 8,341 people for the study. All of them were men.
LikeLike
Hello Sara – honestly, if we didn’t laugh, we’d be crying! Dr. Jill’s example (no women recruited for medical studies) was sadly just one of many studies in our history that became famous for just that reason, as I wrote about several years ago in The Ethical Nag: e.g. the Physicians Health Study, which concluded that taking an aspirin a day might reduce the risk of heart disease, included 22,000 men – and no women. Or the Multiple Risk Factor Intervention Trial, known as Mr. Fit (a longterm study of lifestyle factors related to cholesterol and heart disease) included 13,000 men – and no women. Or a Harvard School of Public Health study investigating the possible link between caffeine consumption and heart disease recruited over 45,000 men – and no women. The list seems endless. . .
Thank you, by the way, for mentioning that Letters From an American article – very interesting!
Take care. . . keep laughing! ❤️
LikeLike
Thank you for standing up for patients! I have multiple chronic healthcare conditions, and am a RN with a Masters of Science in Nursing, and a Patient Advocate.
RNs used to be allowed to advocate for patients, and doctors valued and listened to RNs. Nope, not anymore.
So I decided to become a Board Certified Patient Advocate. To my surprise, not only did doctors become offended, but so did the health care institutions!
How dare I offer information to patients to help them navigate the healthcare system and be able to make informed decisions!?
We hear about patient-centered healthcare. I rarely see it in practice.
LikeLike
Hello Anne,
It’s so discouraging (and alarming!) when an experienced nurse says: “RNs used to be allowed to advocate for patients, and doctors valued and listened to RNs… but not anymore”
RNs are the eyes and ears of the patient/family whenever the doctor is not around (and sometimes even when the doc IS around). This reminds me of frequently observing a common scenario when I worked in palliative care (in communications, not in nursing) – when this kind of phone conversation was often overheard at the front desk: a patient would have orders on the chart for “breakthrough” pain meds if necessary for extreme pain in between scheduled doses, but the patient’s MRP (Most Responsible Physician) – for many patients, this was their family doctor – would first have to approve the breakthrough dose before it was administered. When the MRP was contacted for permission to offer the breakthrough dose, it would often become clear in many, many cases that the family doc had no clue about end-of-life pain management. Meanwhile a nurse with two decades experience working with palliative care patients had to politely wait while the doctor on the other end of the phone hummed and hawed and finally asked: “What do you normally do in cases like this?” The nurses would offer background info on breakthrough doses, and which dose was already listed on the patient’s chart – and the family doc would confidently say “YES that’s what I am recommending too!” – which enabled the nurses to legally provide pain relief.
Imagine – doctors and healthcare institutions being OFFENDED by a Board Certified Patient Advocate!! It says far more about the person being offended than about the quality of the advocacy, doesn’t it?
Take care. . . ❤️
LikeLike
We are from the Institute of Lifetime Learning. . .with a Masters degree in experience.
We are doing research everyday on how to make life better for ourselves and those around us.
LikeLike
Absolutely correct, Jill! ❤️
LikeLike
Good morning Carolyn,
I really enjoyed this article. Also I forwarded it to my daughter.
LikeLike
Thank you! ❤️
LikeLike